Copyright
©2010 Baishideng.
World J Gastroenterol. Apr 14, 2010; 16(14): 1713-1719
Published online Apr 14, 2010. doi: 10.3748/wjg.v16.i14.1713
Published online Apr 14, 2010. doi: 10.3748/wjg.v16.i14.1713
Well-differentiated neuroendocrine tumor (carcinoid) |
Benign: Non-functioning, confined to mucosa-submucosa, non-angioinvasive, < 1 cm in size (ileum) or ≤ 2 cm colon and rectum |
Serotonin-producing tumor |
Enteroglucagon-producing tumor |
Benign or low-grade malignant (uncertain malignant potential): non-functioning, confined to mucosa-submucosa, angioinvasion, or < 1 cm in size (ileum) or ≤ 2 cm colon and rectum |
Serotonin-producing tumor |
Enteroglucagon-producing tumor |
Well-differentiated neuroendocrine carcinoma (malignant carcinoid) |
Low-grade malignant: invasion of the muscularis propria and beyond or metastases |
Non-functioning or functioning serotonin-producing carcinoma (with carcinoid syndrome) |
Non-functioning enteroglucagon-producing carcinoma |
Poorly-differentiated neuroendocrine carcinoma |
High-grade malignant |
- Citation: Ni SJ, Sheng WQ, Du X. Pathologic research update of colorectal neuroendocrine tumors. World J Gastroenterol 2010; 16(14): 1713-1719
- URL: https://www.wjgnet.com/1007-9327/full/v16/i14/1713.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i14.1713